title: Psychiatric symptoms and disorders in phenylketonuria.
abstract: Psychological and psychiatric problems are well documented across the lifespan of individuals with early-treated phenylketonuria (PKU). Early-treated children and adolescents tend to display attentional problems, school problems, lower achievement motivation, decreased social competence, decreased autonomy, and low-self-esteem. As they enter adulthood, early-treated individuals may carry forward low self-esteem and lack of autonomy but also tend to develop depressed mood, generalized anxiety, phobias, decreased positive emotions, social maturity deficits, and social isolation. The correlation between level of metabolic control and severity of symptoms suggests a biological basis of psychiatric dysfunction. Additionally, psychosocial factors such as the burden of living with a chronic illness may contribute to psychological and psychiatric outcomes in PKU. The lack of a PKU-specific psychiatric phenotype combined with the observation that not everyone with PKU is affected highlights the complexity of the problem. More research on psychiatric and psychological outcomes in PKU is required. Of particular importance is the routine monitoring of emotional, behavioral, and psychosocial symptoms in individuals with this metabolic disorder. Longitudinal studies are required to evaluate the impact of new and emerging therapies on psychiatric and psychosocial functioning in PKU. Unidentified or untreated emotional and behavioral symptoms may have a significant, lifelong impact on the quality of life and social status of patients.
authors.affiliation: vlbrumm@sbcglobal.net
authors.forename: V L
authors.initials: VL
authors.lastname: Brumm
authors.forename: D
authors.initials: D
authors.lastname: Bilder
authors.forename: S E
authors.initials: SE
authors.lastname: Waisbren
mesh_terms: D000328:Adult; D002648:Child; D006801:Humans; D001523:Mental Disorders / Q000150:complications*; D010661:Phenylketonurias / Q000150:complications / Q000523:psychology*